HADLEY HOFREITER: Open Payments
NPI 1922686047 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,517 in 77 payments from 17 companies in 2025. Trend: 2023 $581 · 2024 $1,187 · 2025 $1,517
Food & beverage: $1,517
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $382 |
| Amgen Inc. | 9 | $198 |
| PFIZER INC. | 9 | $184 |
| E.R. Squibb & Sons, L.L.C. | 12 | $146 |
| HEARTFLOW, INC. | 3 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| CVRx, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: LEQVIO, REPATHA, VYNDAQEL, CAMZYOS, FFRct, Kerendia, Barostim Neo System, FARXIGA.
Industry payments across CO — which companies pay providers there.
